Cerebrotendinous xanthomatosis: Report of 4 patients

C. Ferrándiz-Pulido, R. Bartralot, M. Girós, P. Bassas, C. Heras, D. Bodet, R. Savall, V. García-Patos

Research output: Contribution to journalArticleResearchpeer-review

3 Citations (Scopus)


Cerebrotendinous xanthomatosis (CTX) is an uncommon autosomal recessive disease caused by mutation of the CYP27A1 gene. It is characterized by the presence of xanthomas in different tissues, principally brain and tendon, due to the accumulation of -cholestanol. Diagnosis is confirmed by measurement of serum -cholestanol and urinary bile alcohol levels. Therapy with chenodeoxycholic acid has been shown to be the most effective treatment and can halt progression of the disease. We present 4 patients with a history of neurological disorders since childhood and who were diagnosed with CTX after developing tendon xanthomas. Although diagnostic suspicion depends to a large extent on recognition of tendon xanthomas, these are not an early sign of the disease, which can present with neurological disorders, cataracts, and chronic diarrhea. Early diagnosis of CTX therefore rests on measurement of serum -cholestanol levels, even in absence of tendon xanthomas. © 2009 Academia Española de Dermatología y Venereología.
Original languageEnglish
Pages (from-to)222-226
JournalActas Dermo-Sifiliograficas
Issue number3
Publication statusPublished - 1 Jan 2009


  • Cerebrotendinous xanthomatosis
  • Chenodeoxycholic acid
  • Cholestanol
  • Sterol 27-hydroxylase
  • Tendon xanthoma


Dive into the research topics of 'Cerebrotendinous xanthomatosis: Report of 4 patients'. Together they form a unique fingerprint.

Cite this